Startups selected for Illumina's genomics incubator in China

By The Science Advisory Board staff writers

November 19, 2021 -- Illumina and investment firm Sequoia Capital China have selected the first two startups to join the Sequoia Capital China Intelligent Healthcare Genomics Incubator located in Zhangjiang Cell Industrial Park, Shanghai.

The incubator serves as a company creation engine focused on supporting life sciences startups that are poised to deliver breakthrough applications in genomics and multiomics, Illumina said.

The startups selected for the inaugural funding cycle include:

  • Mobidrop Biotechnology, a medical device and research tools company developing cutting-edge, single-cell sequencing microfluidic technologies for molecular diagnostics applications
  • Sequanta Technologies, a multiomics company committed to building DNA, RNA, epitome, and proteomics technology platforms for research and clinical applications

Representatives from Mobidrop Biotechnology, Sequanta Technologies, and Illumina.
Entrepreneurs from two startups selected for the inaugural funding cycle of the Sequoia Capital China Intelligent Healthcare Genomics Incubator and a representative of Illumina for Startups China.

Illumina's genomics incubator initiative, Illumina for Startups, is intended to create an innovative ecosystem for the genomics industry by partnering venture capital investors with entrepreneurs to create, launch, and grow genomics startups, Illumina said.

So far this year, Illumina has invested in 61 genomics startups across the globe, which have collectively raised over $1 billion in venture capital funding, the company said. Applications for the second funding cycle are open until March 1, 2022.

Copyright © 2021
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here